Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Tobi Thomas Health and inequalities correspondent

Melanoma patients in England get fast-track access to cancer vaccine

An assistant wearing a white coat and blue gloves conducts cancer vaccine research in the lab putting a liquid into a test tube.
The iSCIB1+ (ImmunoBody) vaccine boosts the immune response to immunotherapy. Photograph: Bloomberg/Getty Images

Patients with an advanced type of skin melanoma in England will be given fast-track access to a “revolutionary” new cancer vaccine as part of an NHS trial.

The vaccine, known as iSCIB1+ (ImmunoBody), helps the immune system recognise cancer cells and therefore better respond to immunotherapy treatment.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.